PMA device
Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge Cassette
Abiomed, Inc. · Temporary Non-Roller Type Left Heart Support Blood Pump (OZD, Class III) · First FDA decision Sep 24, 2019, newest Sep 15, 2025Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
13
Naming "Impella 5.5"
MAUDE reports
8,418
Brand "Impella 5.5", since 2015
PubMed studies
315
Mentioning "Impella 5.5"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge Cassette
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
P140003-S126 · Decided Sep 15, 2025 · 123 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- Impella 5.5 with SmartAssist System; Impella CP with SmartAssist System; Impella 2.5; Impella 5.0; Impella LD;PMA supplement
P140003-S123 · Decided Aug 1, 2025 · 175 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- Impella 5.5 with SmartAssistPMA supplement
P140003-S094 · Decided Oct 4, 2022 · 264 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Impella 5.5", any status and sponsor, newest update first.
University Hospital of CologneAcademic, hospital or other
NCT07655479 · 115 participants (planned) · Start Apr 23, 2026 · Primary completion Oct 2028
Device: Escalation to more capable microaxial flow-pump (Impella 5.5) · For: Cardiogenic Shock Post Myocardial Infarction
Sites: Düsseldorf, Germany; Kiel, Germany; Cologne, Germany
- Left Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive, not recruiting
Abiomed Inc.Public (JNJ)
NCT07943182 · 60 participants (planned) · Start Dec 3, 2024 · Primary completion Dec 2027
Device: Impella CP with SmartAssist; Impella 5.5 with SmartAssist · For: Cardiogenic Shock; Heart Failure; Acute Decompensated Heart Failure (ADHF) and 2 more
Sites: Phoenix, Arizona; Loma Linda, California; Los Angeles, California · 24 sites in all
- Cardiogenic Shock Working Group RegistryRecruiting
Tufts Medical CenterAcademic, hospital or other
NCT04682483 · 20,000 participants (planned) · Start Dec 4, 2017 · Primary completion Dec 2027
Device: Acute Mechanical Circulatory Support Devices · For: Cardiogenic Shock
Sites: Weston, Florida; Chicago, Illinois; Indianapolis, Indiana · 22 sites in all
10 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Impella 5.5", and for the whole product code for context.
This brand
8,418 reports: 3,374 malfunction, 3,944 injury, 1,100 death
Whole product code OZD
46,892 reports: 17,926 malfunction, 23,020 injury, 5,943 death
Newest reports for this brand
- Impella 5.5Malfunction
1220648-2026-14125 · Received Oct 30, 2026 · Event dated Oct 7, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Device Sensing Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Impella 5.5Injury
1220648-2026-13931 · Received Oct 26, 2026 · Event dated Oct 7, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Failure to Advance; Deformation Due to Compressive Stress
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Impella 5.5 with SmartAssist S2 Set, EUMalfunction
1220648-2026-13940 · Received Oct 26, 2026 · Event dated Oct 1, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.Open, Classified
Z-0208-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0209-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0210-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
22 more recall records with a free account
Published research
The most relevant PubMed records for "Impella 5.5"[tiab]. The summary above synthesizes these.
- Clinical management of the Impella 5.5 pump.
Bernhardt AM, Blumer V, Vandenbriele C, et al. · J Heart Lung Transplant · 2025Review
- [Impella 5.5 Implantation Technique for Surgeons].
Toda K · Kyobu Geka · 2024English Abstract
- Implanting Impella 5.5 under Local Anesthesia.
Eghbalzadeh K, Wahlers TCW, Deppe AC · Thorac Cardiovasc Surg · 2024
- Impella 5.5: A Systematic Review of the Current Literature.
Valdes CA, Bilgili A, Reddy A, et al. · Innovations (Phila) · 2024Systematic Review
- Extended Support With the Impella 5.5: Transplant, ECMO, and Complications.
Cohen WG, Rekhtman D, Iyengar A, et al. · ASAIO J · 2023
- Impella 5.5 Placement Across Evolut FX Transcatheter Aortic Valve: Balloon-Assisted Procedure.
Narita M, Nishijima S, Katagiri Y, et al. · Ann Thorac Surg Short Rep · 2024
- The Use of Impella 5.5 for Donor-Heart Hemodynamic Support in Heart Transplantation.
Kawabori M, David B, Nordan T, et al. · ASAIO J · 2023
- Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States.
Cevasco M, Shin M, Cohen W, et al. · Clin Transplant · 2023
- Impella 5.5 Direct Aortic Implant and Explant Techniques.
Anderson M, Smith D, Kane P, et al. · Ann Thorac Surg · 2021Technical Report
- Impella CP to Impella 5.5 Uninterrupted Upgrade Using a Double Device Technique.
Salas De Armas I, Patel MK, Akay M, et al. · ASAIO J · 2022
- Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility.
Roka-Moiia Y, Li M, Ivich A, et al. · ASAIO J · 2020Comparative Study, Research Support, Non-U.S. Gov't
- Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's Witness.
Devich R, Neuendorff NR, Frazier OH, et al. · ASAIO J · 2023
Other devices of this type
Also filed under product code OZD.
- Impella 2.5Abiomed, Inc. · PMA 2025
- Impella Ventricular Support SystemsAbiomed, Inc. · PMA 2023
- Impella CP with SmartAssistAbiomed, Inc. · PMA 2025
- Impella 2.5, Impella CP and CP with SmartAssistAbiomed, Inc. · PMA 2023
- Impella Left Ventricular Support SystemsAbiomed, Inc. · PMA 2021
- Automated Impella ControllerAbiomed, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.